Blood cancers

Understanding MM heterogeneity may help the pursuit of a cure

Sponsored by Amgen Australia Pty Ltd

In a recent Amgen-sponsored Multiple Myeloma Expert Forum in July 2021, Dr Leo Rasche (attending physician on the myeloma service at the University Hospital of Würzburg, Germany) and Professor Gordon Cook (Clinical Director Haematology, Leeds Institute of Clinical Trials Research, University of Leeds, UK) gave their perspectives on delineating tumour heterogeneity in multiple myeloma (MM) ...

Already a member?

Login to keep reading.

© 2021 the limbic